Young Lung Cancer Initiative Podcast
Once you know you have HER2 lung cancer, what comes next? In Part 2 of our HER2-driven lung cancer series, Leah Phillips and thoracic medical oncologist Dr. Kyle Concannon (UC Health, University of Colorado) walk through what treatment actually looks like. They cover how first-line decisions are made for early versus advanced disease, where HER2-targeted therapies fit in, how doctors tell whether a treatment is working, what brain monitoring looks like, and what a progression conversation involves. Whether you're newly diagnosed or supporting someone through treatment, this episode will help you walk into your next oncology appointment more prepared. Thanks to Boehringer Ingelheim for supporting this series. YLCI retains full editorial control. This content is for informational purposes only and is not medical advice. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
24 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Young Lung Cancer Initiative Podcast!